Wednesday, June 10, 2026

pharma Β· Major Depressive Disorder Β· Migraine Β· AXSM

Axsome Therapeutics

Axsome Therapeutics clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

One World Trade Center, New York, NY 10007, US HQ
2012 Founded
981 Employees
Public company Type
AXSM Β· NYSE Ticker
Company details
Status
Public
HQ
One World Trade Center, New York, NY 10007, US
Founded
2012
Employees
981
Programs
28
Drugs
12
Patents
162
Intelligence Β· Clinical Programs

Axsome Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Axsome Therapeutics.

Axsome Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Solriamfetol 150 mg Oral Tablet

    Axsome Therapeutics

    Narcolepsy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Axsome Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.